oleanolic acid has been researched along with Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamford, RN; Bryant, BR; Conlon, KC; Daenthanasanmak, A; Green, PL; Homan, P; Karim, B; Miljkovic, MD; Petrus, MN; Thomas, CJ; Waldmann, TA; Yang, SM; Yoshioka, M | 1 |
| Banerjee, S; Rabi, T | 1 |
| Chieng, YC; Hong, PL; Hoon, LS; Hsum, YW; Mooi, LY; Soo, KK; Yew, WT | 1 |
| Andreeff, M; Bernstein, SH; Brookes, PS; Hilchey, SP; Lee, J; Li, M; Lu, B; Metcalfe, HM; Morse, KM; Skalska, J; Suzuki, CK; Venkatesh, S | 1 |
| Andreeff, M; Dezube, BJ; Eder, JP; Ferguson, DA; He, X; Hong, DS; Konoplev, S; Konopleva, M; Kufe, D; Kurzrock, R; Lawrence, D; Lazarus, H; Meyer, CJ; Mier, J; Naing, A; Shapiro, GI; Supko, JG; Wheler, J | 1 |
1 trial(s) available for oleanolic acid and Lymphoma
| Article | Year |
|---|---|
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Colorectal Neoplasms; Cyclin D1; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Janus Kinases; Kidney Neoplasms; Lymphoma; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; NAD(P)H Dehydrogenase (Quinone); Neoplasms; NF-E2-Related Factor 2; NF-kappa B; Oleanolic Acid; RNA, Messenger; STAT Transcription Factors; Thyroid Neoplasms; Young Adult | 2012 |
4 other study(ies) available for oleanolic acid and Lymphoma
| Article | Year |
|---|---|
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Topics: Animals; Basic-Leucine Zipper Transcription Factors; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukocytes, Mononuclear; Lymphoma; Mice; NF-kappa B; Oleanolic Acid; Phosphatidylinositol 3-Kinases | 2022 |
Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Lymphoma; Mice; Oleanolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Telomerase; Triterpenes | 2009 |
Cancer chemopreventive activity of maslinic acid: suppression of COX-2 expression and inhibition of NF-κB and AP-1 activation in Raji cells.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Gene Expression; Humans; Lymphoma; NF-kappa B; Oleanolic Acid; Signal Transduction; Transcription Factor AP-1; Triterpenes | 2011 |
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives.
Topics: Cell Line; Cell Survival; Enzyme Activation; Gene Knockdown Techniques; Humans; Inclusion Bodies; Lymphoma; Lymphoma, B-Cell; Mitochondria; Oleanolic Acid; Protease La; Proteasome Endopeptidase Complex; Protein Binding; Up-Regulation | 2012 |